Scott Akamine - Net Worth and Insider Trading

Scott Akamine Net Worth

The estimated net worth of Scott Akamine is at least $307,355 dollars as of 2024-04-28. Scott Akamine is the Chief Legal Officer of Cerevel Therapeutics Holdings Inc and owns about 7,237 shares of Cerevel Therapeutics Holdings Inc (CERE) stock worth over $307,355. Details can be seen in Scott Akamine's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott Akamine has not made any transactions after 2023-12-20 and currently still holds the listed stock(s).

Transaction Summary of Scott Akamine

To

Scott Akamine Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott Akamine owns 1 companies in total, including Cerevel Therapeutics Holdings Inc (CERE) .

Click here to see the complete history of Scott Akamine’s form 4 insider trades.

Insider Ownership Summary of Scott Akamine

Ticker Comapny Transaction Date Type of Owner
CERE Cerevel Therapeutics Holdings Inc 2023-12-20 Chief Legal Officer

Scott Akamine Latest Holdings Summary

Scott Akamine currently owns a total of 1 stock. Scott Akamine owns 7,237 shares of Cerevel Therapeutics Holdings Inc (CERE) as of December 20, 2023, with a value of $307,355.

Latest Holdings of Scott Akamine

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CERE Cerevel Therapeutics Holdings Inc 2023-12-20 7,237 42.47 307,355

Holding Weightings of Scott Akamine


Scott Akamine Form 4 Trading Tracker

According to the SEC Form 4 filings, Scott Akamine has made a total of 3 transactions in Cerevel Therapeutics Holdings Inc (CERE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Cerevel Therapeutics Holdings Inc is the sale of 7,072 shares on December 20, 2023, which brought Scott Akamine around $292,922.

Insider Trading History of Scott Akamine

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Scott Akamine Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Scott Akamine Ownership Network

Ownership Network List of Scott Akamine

No Data

Ownership Network Relation of Scott Akamine


Scott Akamine Owned Company Details

What does Cerevel Therapeutics Holdings Inc do?

Who are the key executives at Cerevel Therapeutics Holdings Inc?

Scott Akamine is the Chief Legal Officer of Cerevel Therapeutics Holdings Inc. Other key executives at Cerevel Therapeutics Holdings Inc include director & See Remarks N Anthony Coles , Chief Scientific Officer John Renger , and Chief Medical Officer Ramiro Sanchez .

Cerevel Therapeutics Holdings Inc (CERE) Insider Trades Summary

Over the past 18 months, Scott Akamine made 2 insider transaction in Cerevel Therapeutics Holdings Inc (CERE) with a net sale of 24,572. Other recent insider transactions involving Cerevel Therapeutics Holdings Inc (CERE) include a net sale of 802,506 shares made by N Anthony Coles , a net sale of 37,652 shares made by Ramiro Sanchez , and a net sale of 27,161 shares made by John Renger .

In summary, during the past 3 months, insiders sold 154,667 shares of Cerevel Therapeutics Holdings Inc (CERE) in total and bought 0 shares, with a net sale of 154,667 shares. During the past 18 months, 1,166,157 shares of Cerevel Therapeutics Holdings Inc (CERE) were sold and 17,422,701 shares were bought by its insiders, resulting in a net purchase of 16,256,544 shares.

Cerevel Therapeutics Holdings Inc (CERE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cerevel Therapeutics Holdings Inc Insider Transactions

No Available Data

Scott Akamine Mailing Address

Above is the net worth, insider trading, and ownership report for Scott Akamine. You might contact Scott Akamine via mailing address: C/o Aeon Biopharma, Inc., 4040 Macarthur Blvd., Suite 260, Newport Beach Ca 92660.

Discussions on Scott Akamine

No discussions yet.